Aug 20, 2018
Thrombosis Research Institute (TRI) to Announce New Real-World Insights in Atrial Fibrillation at ESC Congress 2018
Aug 07, 2018
Global Anticoagulants Market Expected to Reach $43,427 Million by 2025, Says Allied Market Research
Jul 19, 2018
Statement from FDA warning about significant health risks of contaminated illegal synthetic cannabinoid products that are being encountered by FDA
Jul 10, 2018
Huntington Hospital Performs First WATCHMAN(TM) Left Atrial Appendage Closure to Treat Patients with Atrial Fibrillation
Jul 06, 2018
Thrombosis Drugs Market to be Worth US$ 47 Bn by 2026, Says TMR
Jun 18, 2018
Mylan Launches Generic Angiomax® Injection
Jun 15, 2018
Feinstein Institute scientist recognized for anticoagulation management practices
Jun 11, 2018
CryoLife Announces Peer Review Publication of On-X® Aortic Heart Valve PROACT Study
May 23, 2018
CeloNova Announces Positive Clinical Results of eCOBRA Study at EuroPCR 2018
May 16, 2018
Greater Burden of Atrial Fibrillation Linked to Higher Stroke Risk
May 14, 2018
Parker Waichman LLP is Investigating Potential Neurovascular Stent Claims Following Recent FDA Safety Alert
Apr 18, 2018
Point of Care Decision Support Announces New Software Release for Anticoagulation (AC) Software
Apr 17, 2018
FDA Provides Full Approval to Praxbind, Specific Reversal Agent for Pradaxa
Apr 09, 2018
Houston Methodist The Woodlands Hospital is first hospital in The Woodlands to offer an alternative to long-term warfarin medication to reduce the risk of stroke
Mar 09, 2018
Boehringer Ingelheim to Present New Research on Pradaxa and Specific Reversal Agent Praxbind at American College of Cardiology Scientific Session
Feb 14, 2018
After multiple failed procedures at other medical institutions, Colorado man successfully treated for Atrial Fibrillation at Texas Cardiac Arrhythmia Institute at St. David's Medical Center
Feb 13, 2018
GC Pharma and Lee's Pharm Enter into China Licensing Agreement to Develop and Commercialise GCC-4401C, an Investigational Anticoagulant
Feb 08, 2018
Global Unfractionated Heparin Market is Projected to Reach Valuation of US$1664.4 Million by 2025: Transparency Market Research
Jan 11, 2018
First Patient Enrolled in U.S. IDE Study To Evaluate the Potential of New Device To Reduce Stroke Risk in Atrial Fibrillation Patients
Jan 02, 2018
United States Left Atrial Appendage Closure Devices Market 2018